175 related articles for article (PubMed ID: 17823852)
21. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
Sanz-Ortega J; Saez MC; Sierra E; Torres A; Balibrea JL; Hernando F; Sanz-Esponera J; Merino MJ
J Pathol; 2001 Nov; 195(4):429-34. PubMed ID: 11745674
[TBL] [Abstract][Full Text] [Related]
22. High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer.
Oesterreich S; Allredl DC; Mohsin SK; Zhang Q; Wong H; Lee AV; Osborne CK; O'Connell P
Br J Cancer; 2001 Feb; 84(4):493-8. PubMed ID: 11207044
[TBL] [Abstract][Full Text] [Related]
23. High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene.
Farrand K; Delahunt B; Wang XL; McIver B; Hay ID; Goellner JR; Eberhardt NL; Grebe SK
J Clin Endocrinol Metab; 2002 Oct; 87(10):4715-21. PubMed ID: 12364463
[TBL] [Abstract][Full Text] [Related]
24. Loss of heterozygosity on chromosome 16p and 18q in anaplastic thyroid carcinoma.
Kadota M; Tamaki Y; Sekimoto M; Fujiwara Y; Aritake N; Hasegawa S; Kobayashi T; Ikeda T; Horii A; Monden M
Oncol Rep; 2003; 10(1):35-8. PubMed ID: 12469141
[TBL] [Abstract][Full Text] [Related]
25. A comprehensive analysis of MNG1, TCO1, fPTC, PTEN, TSHR, and TRKA in familial nonmedullary thyroid cancer: confirmation of linkage to TCO1.
Bevan S; Pal T; Greenberg CR; Green H; Wixey J; Bignell G; Narod SA; Foulkes WD; Stratton MR; Houlston RS
J Clin Endocrinol Metab; 2001 Aug; 86(8):3701-4. PubMed ID: 11502798
[TBL] [Abstract][Full Text] [Related]
26. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
27. Loss of heterozygosity (LOH) in tumour suppressor genes in benign and malignant mixed odontogenic tumours.
Galvão CF; Gomes CC; Diniz MG; Vargas PA; de Paula AM; Mosqueda-Taylor A; Loyola AM; Gomez RS
J Oral Pathol Med; 2012 May; 41(5):389-93. PubMed ID: 22082131
[TBL] [Abstract][Full Text] [Related]
28. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
29. Functional loss of tumor suppressor genes detected by loss of heterozygosity, but not driver mutations, predicts aggressive lymph node status in papillary thyroid carcinoma.
Finkelstein S; Timmaraju VA; Samankan S; O'Malley Q; Kapustin D; Spaulding S; Xing M; Matloob A; Beute J; Seo G; Saturno M; Greenberg L; Wein L; Gonzalez-Velazquez C; Doyle S; Levine J; Urken M; Brandwein-Weber M
Pathol Res Pract; 2023 Nov; 251():154842. PubMed ID: 37890270
[TBL] [Abstract][Full Text] [Related]
30. Loss of heterozygosity at microsatellite marker sites for tumour suppressor genes in oesophageal adenocarcinoma.
Morgan RJ; Newcomb PV; Bailey M; Hardwick RH; Alderson D
Eur J Surg Oncol; 1998 Feb; 24(1):34-7. PubMed ID: 9542513
[TBL] [Abstract][Full Text] [Related]
31. Allele loss and mutation screen at the Peutz-Jeghers (LKB1) locus (19p13.3) in sporadic ovarian tumours.
Wang ZJ; Churchman M; Campbell IG; Xu WH; Yan ZY; McCluggage WG; Foulkes WD; Tomlinson IP
Br J Cancer; 1999 Apr; 80(1-2):70-2. PubMed ID: 10389980
[TBL] [Abstract][Full Text] [Related]
32. [Loss of heterozygosity on chromosome 9p13-23 in microdissected laryngeal squamous cell carcinoma by microsatellite analysis].
Xu X; An Q; Zhang J; Tang P; Cheng S
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):367-71. PubMed ID: 12761947
[TBL] [Abstract][Full Text] [Related]
33. [Loss of heterozygosity of tumor suppressor genes at chromosome 3p in transitional cell carcinoma of urinary bladder].
Xiao Z; Zhang J; Zheng S; Li C; He Z; Cheng S; Gao Y
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1375-7. PubMed ID: 12509916
[TBL] [Abstract][Full Text] [Related]
34. [Loss of heterozygosity on chromosome 3p in thyroid tumors].
Hu MJ; Xu HD; Zhou R; Li XF; Zhang HY
Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):305-8. PubMed ID: 18956647
[TBL] [Abstract][Full Text] [Related]
35. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.
Grebe SK; McIver B; Hay ID; Wu PS; Maciel LM; Drabkin HA; Goellner JR; Grant CS; Jenkins RB; Eberhardt NL
J Clin Endocrinol Metab; 1997 Nov; 82(11):3684-91. PubMed ID: 9360526
[TBL] [Abstract][Full Text] [Related]
36. A Greek family with a follicular variant of familial papillary thyroid carcinoma: TCO, MNG1, fPTC/PRN, and NMTC1 excluded as susceptibility loci.
Tsilchorozidou T; Vafiadou E; Yovos JG; Romeo G; McKay J; Lesueur F; Bonora E
Thyroid; 2005 Dec; 15(12):1349-54. PubMed ID: 16405407
[TBL] [Abstract][Full Text] [Related]
37. Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors.
Zhang JS; Nelson M; McIver B; Hay ID; Goellner JR; Grant CS; Eberhardt NL; Smith DI
Oncogene; 1998 Aug; 17(6):789-93. PubMed ID: 9715281
[TBL] [Abstract][Full Text] [Related]
38. LOH detected by microsatellite markers reveals the clonal origin of recurrent laryngeal squamous cell carcinoma.
Cui Z; Pan X; Wang Q
PLoS One; 2014; 9(11):e111857. PubMed ID: 25365429
[TBL] [Abstract][Full Text] [Related]
39. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
[TBL] [Abstract][Full Text] [Related]
40. Loss of heterozygosity (LOH), malignancy grade and clonality in microdissected prostate cancer.
Hügel A; Wernert N
Br J Cancer; 1999 Feb; 79(3-4):551-7. PubMed ID: 10027329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
